PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.230
+0.110 (2.67%)
At close: Apr 8, 2026, 4:00 PM EDT
4.195
-0.035 (-0.83%)
After-hours: Apr 8, 2026, 4:10 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $80.72 million as of April 8, 2026. Its market cap has increased by 181.89% in one year.
Market Cap
80.72M
Enterprise Value
68.87M
1-Year Change
181.89%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $80.72M, a decrease of -2.08%. That is a compound annual growth rate of -0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 78.62M | 8.90% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 83.97M |
| NeurAxis | 82.01M |
| Filana Therapeutics | 81.40M |
| Champions Oncology | 81.14M |
| Pliant Therapeutics | 80.49M |
| Rani Therapeutics Holdings | 80.03M |
| Estrella Immunopharma | 78.50M |
| aTyr Pharma | 78.14M |